At R$4.29, Is Trisul S.A. (BVMF:TRIS3) Worth Looking At Closely?

By
Simply Wall St
Published
March 14, 2022
BOVESPA:TRIS3
Source: Shutterstock

While Trisul S.A. (BVMF:TRIS3) might not be the most widely known stock at the moment, it saw significant share price movement during recent months on the BOVESPA, rising to highs of R$6.57 and falling to the lows of R$4.29. Some share price movements can give investors a better opportunity to enter into the stock, and potentially buy at a lower price. A question to answer is whether Trisul's current trading price of R$4.29 reflective of the actual value of the small-cap? Or is it currently undervalued, providing us with the opportunity to buy? Let’s take a look at Trisul’s outlook and value based on the most recent financial data to see if there are any catalysts for a price change.

Check out our latest analysis for Trisul

What is Trisul worth?

The share price seems sensible at the moment according to my price multiple model, where I compare the company's price-to-earnings ratio to the industry average. I’ve used the price-to-earnings ratio in this instance because there’s not enough visibility to forecast its cash flows. The stock’s ratio of 4.95x is currently trading slightly below its industry peers’ ratio of 7.36x, which means if you buy Trisul today, you’d be paying a decent price for it. And if you believe Trisul should be trading in this range, then there isn’t much room for the share price to grow beyond the levels of other industry peers over the long-term. Is there another opportunity to buy low in the future? Since Trisul’s share price is quite volatile, we could potentially see it sink lower (or rise higher) in the future, giving us another chance to buy. This is based on its high beta, which is a good indicator for how much the stock moves relative to the rest of the market.

Can we expect growth from Trisul?

earnings-and-revenue-growth
BOVESPA:TRIS3 Earnings and Revenue Growth March 14th 2022

Future outlook is an important aspect when you’re looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company's future expectations. Trisul's earnings over the next few years are expected to increase by 44%, indicating a highly optimistic future ahead. This should lead to more robust cash flows, feeding into a higher share value.

What this means for you:

Are you a shareholder? TRIS3’s optimistic future growth appears to have been factored into the current share price, with shares trading around industry price multiples. However, there are also other important factors which we haven’t considered today, such as the financial strength of the company. Have these factors changed since the last time you looked at TRIS3? Will you have enough confidence to invest in the company should the price drop below the industry PE ratio?

Are you a potential investor? If you’ve been keeping an eye on TRIS3, now may not be the most optimal time to buy, given it is trading around industry price multiples. However, the positive outlook is encouraging for TRIS3, which means it’s worth diving deeper into other factors such as the strength of its balance sheet, in order to take advantage of the next price drop.

If you want to dive deeper into Trisul, you'd also look into what risks it is currently facing. At Simply Wall St, we found 2 warning signs for Trisul and we think they deserve your attention.

If you are no longer interested in Trisul, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

Discounted cash flow calculation for every stock

Simply Wall St does a detailed discounted cash flow calculation every 6 hours for every stock on the market, so if you want to find the intrinsic value of any company just search here. It’s FREE.

Make Confident Investment Decisions

Simply Wall St's Editorial Team provides unbiased, factual reporting on global stocks using in-depth fundamental analysis.
Find out more about our editorial guidelines and team.